Osteoclastogenesis in metastatic bone cancer has been suggested to be mediated by CD137L-CD137 signaling pathway where CD137 enhances monocyte/macrophage migration and differentiation to osteoclasts (122) (Figure 1). This evidence concerns the gene TNFRSF9 and bone neoplasm.